Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Oct 07, 2024	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-24-106432.pdf 0001104659-24-106432.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Oct 03, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-24-000129.pdf 0001968202-24-000129.xls
Oct 03, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-24-000130.pdf 0001968202-24-000130.xls
Oct 01, 2024	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001950047-24-007484.pdf 0001950047-24-007484.xls
Sep 11, 2024	UPLOAD	UPLOAD	View HTML 0000000000-24-010260.pdf
Sep 05, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-24-000124.pdf 0001968202-24-000124.xls
Sep 05, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-24-000125.pdf 0001968202-24-000125.xls
Sep 05, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-24-000126.pdf 0001968202-24-000126.xls
Sep 03, 2024	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001950047-24-006679.pdf 0001950047-24-006679.xls
Aug 29, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-24-000045.pdf 0001883850-24-000045.xls

Data provided by Kaleidoscope.

Investors & Media